



Glutathione depletion in human erythrocytes and rat
liver: a study on the interplay between bioactivation
and inactivation functions of liver and blood
Citation for published version (APA):
Palmen, N. G. M., & Evelo, C. T. A. (1996). Glutathione depletion in human erythrocytes and rat liver: a
study on the interplay between bioactivation and inactivation functions of liver and blood. Toxicology in
Vitro, 10, 273-281. https://doi.org/10.1016/0887-2333(96)00002-1





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Nov. 2021
Pergnmon Toxicology in Vitro 10 (1996) 273-281 
Glutathione Depletion in Human 
Erythrocytes and Rat Liver: a Study on 
the Interplay Between Bioactivation and 
Inactivation Functions of Liver and Blood 
N. G. M. PALMEN? and C. T. A. EVELO* 
Department of Pharmacology, Toxicology Section, University of Limburg, PO Box 616, 
6200 MD Maastricht, The Netherlands 
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Abstract--The interplay between bioactivation and inactivation functions of human erythrocytes and 
rat liver was studied. Glutathione depletion was used as a measure of the amount of reduced glutathione 
(GSH)-reactive compound. Iodoacetamide (IAcA), N-ethylmaleimide (NEM) and diethyl maleate 
(DEM), which are electrophiles that need no metabolic activation, were able to deplete GSH in incubations 
with either aqueous GSH solution or erythrocytes. These results indicate that these compounds can pass 
the erythrocyte membrane. Cyclophosphamide (CP), 3-hydroxyacetanilide (3-HAA) and 2-methylfurane 
(2.MF) needed metabolic activation by rat liver microsomes to deplete glutathione in incubations with 
aqueous GSH solution or erythrocytes. By measuring the sum of both reduced and oxidized glutathione 
[ = total glutathione (CT)] it became clear that GSH-reactive metabolites are generated out of CP, 3-HAA 
and 2-MF by the action of microsomes and that these metabolites can pass through the erythrocyte 
membrane. As CT depletion was higher when microsomes of phenobarbital-pretreated rats were used, the 
metabolites were (are expected to be) generated by phenobarbital-inducible enzymes. CT was also depleted 
in incubations with haemolysate and 3-HAA or 2-MF but not in incubations with aqueous GSH solution, 
which indicates that erythrocyte cytosol can metabolize 3-HAA and 2-MF into GSH-reactive compounds. 
The pesticides monuron and monulinuron did not affect CT concentrations when aqueous GSH solution, 
haemolysate or erythrocytes with or without microsomal activating system were tested. When hepatocytes 
were incubated with 3-HAA or CP (2 mM), about 2 mM of internal CT concentration was depleted. The 
hepatocytes excreted GSH-reactive metabolites generated from 3-HAA and CP (about 20% of the 
metabolites formed for 3-HAA). Erythrocyte CT was not depleted m co-incubations of hepatocytes and 
erythrocytes with 3-HAA. This can be explained by the amounts of GSH-reactive metabolites excreted 
by the hepatocytes, which would require very effective uptake by the erythrocytes in order to be detectable. 
Copyright 0 1996 Elsevier Science Ltd 
INTRODUCTION 
Glutathione in its reduced form (GSH) and gluta- 
thione S-transferase (GST) have key roles in the 
detoxification of electrophilic compounds (DeLeve 
and Kaplowitz, 1991; Mannervik and Danielson, 
1988; Meister and Anderson, 1983). Human erythro- 
cytes contain a high concentration of GSH (about 
2mhr) (Fazi et al., 1991) and a relatively high GST 
activity (16 U haemoglobin/g towards the common 
*Author for correspondence. 
ICurrent address: Arbodienst Limburg, Maastricht, The 
Netherlands. 
Abbreviations: CP = cyclophosphamide; DEM = diethyl 
maleate; GSH = reduced glutathione; GST = glutathi- 
one S-transferase; CT = total glutathione; 3-HAA = 
3-hydroxyacetanilide; IAcA = iodoacetamide; LDH = 
lactate dehydrogenase; MAS = microsomal activating 
system; 2-MF = 2-methylfurane; MFO = mixed-function 
oxidase; MLN = monulinuron; NEM = N-ethylmale- 
imide; PB = phenobarbital; PBS = phosphate buffered 
saline; TCA = trichloracctic acid. 
substrate I-chloro-2,4_dinitrobenzene) (Evelo and 
Henderson, 1992; Strange et al., 1982). Erythrocytes 
may therefore act as circulating bioreactors, conju- 
gating electrophiles near or in the tissues where they 
originate. This may lead to consumption of erythro- 
cyte GSH, and, in fact, various electrophiles are 
known to cause glutathione depletion in human 
erythrocytes in vitro (Calabrese et al., 1988; Evelo and 
Henderson, 1988; Fazi et al., 1991) and in vivo (Evelo 
and Henderson, 1992; Mulders, 1995). 
Erythrocytes also contain mixed-function oxidase 
(MFO) activity capable of generating GSH-reactive 
compounds, an activity that according to Belvedere 
and Tursi (1981) must be attributed to oxyhaemo- 
globin. Erythrocytes are, for instance, known to 
metabolize styrene into styrene oxide (Belvedere and 
Tursi, 1981; Norppa et al., 1983; Tursi et al., 1983). 
benzo[a]pyrene into quinones (Lo Jacono et al., 1992) 
and heterocyclic amines into intermediates with 
mutagenic activity (Duverger-van Bogaert et al., 
1991), to hydroxylate aniline (Mieyal et al., 1976), 
0887-2333/96/%15.00 + 0.00 Copyright 0 1996 Elsevier Science Ltd. All rights reserved. Printed in Great Britain 
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and to perform oxidative demethylation on methyl- 
aniline with concomitant release of formaldehyde 
(Stecca and Duverger-van Bogaert, 1989). 
For most compounds, the activity of electrophilic 
metabolite formation is much higher in the liver than 
in erythrocytes (Guengerich and Liebler, 1985). 
Although liver-generated electrophilic metabolites 
may be detoxified within the hepatocytes, they can 
also be excreted, enter the erythrocytes in the 
sinusoids and deplete erythrocyte glutathione. 
In the present investigation, attention was paid 
to the interplay between the bioactivation and in- 
activation functions of liver and blood. The main 
questions, approached in vitro, were as follows: 
What is the importance of the bioactivating 
and inactivating potency of red blood cells in 
comparison with the hepatic capacity? 
Are erythrocytes accessible for GSH-reactive 
electrophilic compounds? 
Is the outer cell membrane of hepatocytes a 
barrier to reactive metabolites formed intra- 
cellularly, or is an effective detoxification 
occurring intrahepatically? 
We developed an incubation system using different 
combinations of human erythrocytes, haemolysate 
and aqueous GSH solution with rat liver micro- 
somes or intact hepatocytes to mimic the in uioo 
situation. The choice of two different species for 
target cells (human erythrocytes) and metabolizing 
GSH solution Haemolysate Erythrocytes 
Fig. 1. An outline of the incubations performed in this 
study. GSH-reactive compounds (X) can react with GSH in 
aqueous solution or in haemolysates; if they are able to enter 
the erythrocyte they can also have this effect in this cell type. 
Non GSH-reactive compounds can sometimes be metab- 
olized into reactive compounds (X’). This can occur either 
in the erythrocyte itself, provided that the parent compound 
can enter the cell (if this is not the case effects may be seen 
only in haemolysates), or by added metabolic systems such 
as MAS or hepatocytes. The diagram is further explained in 
the text. 
cells (rat hepatocytes) was made to obtain an optimal 
combination of significance (human target, no 
substances with known qualitative differences in 
metabolism across species used) and feasibility 
(rodent liver, no large volumes of rodent blood). The 
test systems can easily be adapted to use human 
liver-derived activating systems, or blood of larger 
animals that may sometimes be more readily 
available. 
An outline of the various experimental conditions 
studied in the present investigation is shown in Fig. 1. 
Direct reactivity of the substrate (X) with GSH was 
tested in incubations with aqueous GSH solutions 
(arrow 1, Fig. 1). Metabolic activity of erythrocytes 
for the test substrates (MFO plus GST) was tested 
through comparison of incubations with aqueous 
GSH solution and incubations with haemolysate 
(arrow 2). The influence of erythrocyte integrity on 
uptake and metabolism of the test compounds was 
tested by comparison of incubations with haemo- 
lysate and erythrocytes (arrow 3). This influence may 
consist of effects of the membrane on uptake and, for 
example, of differences in reductive capacity due to 
higher oxygen exposure of the haemolysates. 
Biotransformation of the test compound by means 
of a microsomal activating system (MAS) into gluta- 
thione-reactive metabolites was tested through incu- 
bations with aqueous GSH solution with (arrow 1’) 
and without MAS (arrow I). These incubations were 
compared with incubations in which erythrocytes and 
MAS were combined (arrow 3’). 
Biotransformation of the test compound by 
hepatocytes (both phase I and phase II activity) was 
assessed by determination of glutathione depletion. 
The ability of GSH-reactive metabolites to pass the 
hepatocyte membrane was also tested. Therefore, 
after incubation of substrate with hepatocytes, the 
intact cells were removed by centrifugation and 
the supernatant was incubated again with GSH 
(arrow I’). Co-incubations of hepatocytes and 
erythrocytes (arrow 3’) were used to test whether 
metabolites generated and excreted by hepatocytes 
are able to enter the erythrocyte and deplete erythro- 
cyte glutathione. 
MATERIALS AND METHODS 
Chemicals 
Reduced glutathione (GSH), glucose-6-phosphate 
dehydrogenase (G6PDH; EC I. 1.1.49), glutathione 
reductase (EC 1.6.4.2), P-glucuronidase/arylsulfatase 
(EC 3.2.1.31/EC 3.1.6.1), glucosed-phosphate (G6P), 
NADP(H), NADH, cyclophosphamide (CP; CAS 
no. 6055-19-2) and 3-hydroxyacetanilide (3-HAA; 
CAS no. 621-42-1) were obtained from Sigma (St 
Louis, MO, USA). Diethyl maleate (DEM), N- 
ethylmaleimide (NEM) and iodoacetamide (IAcA) 
were from Janssen Chimica (Beerse, Belgium). 2- 
Methylfurane (2-MF; CAS no. 534-22-5) was from 
Merck (Darmstadt, Germany), and monuron (MN; 
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CAS no. 150-68-S) and monulinuron (MLN; CAS 
no. 1746-81-2) were from Riedel-de Haen (Seelse, 
Germany). Collagenase B (from Cfostridium histo- 
lyticum) was obtained from Boehringer (Mannheim, 
Germany). Water was demineralized and micro- 
filtered before use. All other chemicals were of 
analytical grade. 
Animals 
Male Brown Norway rats (BN/M) of about 250 g 
were used. Housing was as previously described 
(Palmen and Evelo, 1993). For phenobarbital pre- 
treatment the animals received 1 g/litre of the sub- 
stance in their drinking water for 1 wk prior to the 
preparation of microsomes (PB microsomes). 
Biological preparations 
The preparation of the microsomal activating sys- 
tem was as described previously (Palmen and Evelo, 
1993). The procedure for the isolation of hepatocytes 
was based on the methods described by Berry and 
Friend (1969) and by Seglen (1973). Viability of the 
cells (more than 90%) was determined with the 
trypan blue exclusion test (Jauregui et al., 1981). All 
incubations using hepatocytes (both with and without 
erythrocytes) were performed in Krebs-Henseleit 
buffer of pH 7.4. Erythrocytes and haemolysates were 
prepared as previously described (Palmen and Evelo, 
1993). 
Incubations 
The chemicals tested can be divided into direct 
GSH-reactive compounds (IAcA, NEM, DEM) and 
compounds that need further metabolization into 
GSH-reactive metabolites (CP, 3-HAA, 2-MF) 
(Garle and Fry, 1989). Two pesticides (MN and 
MLN) were also tested because their metabolite 
(4-chloroaniline) is known to generate haemoglobin 
adducts (Sabbioni and Neumann, 1990). As the gluta- 
thione sullhydryl group is more sensitive to alkyla- 
tion than the haemoglobin sulfhydryl group (Evelo 
and Henderson, 1988), MN and MLN might also 
affect glutathione concentrations. 
Direct GSH-reactive compounds. Whole blood 
(1.5 ml) or an equal volume of aqueous GSH solution 
in phosphate buffered saline (PBS, pH 7.3), were 
incubated in a shaking water-bath (37°C 210rpm) 
with 50 ~1 of the test compounds IAcA, DEM and 
NEM. Final concentrations were 0, 0.5, 1.0 or 
2 mM. IAcA and NEM were dissolved in PBS, 
and DEM in 100% ethanol. Addition of ethanol 
alone had no effect on the GSH values. The remain- 
ing GSH concentrations were determined after an 
incubation period of 1 hr for GSH solutions (initial 
concentration 500 PM) and of 15 min for human 
blood (initial GSH concentrations 860, 820 and 
72Op~, for IAcA, DEM and NEM, respectively). 
All these experiments were performed in triplicate 
(1 x 3). 
Other compounds. 2 ml aqueous GSH solution, 
haemolysate or erythrocytes (final Hb concentrations 
57 and 23 g/litre respectively) in 100 rfIM Na2HP04/ 
KHzPOl buffer (pH 7.4) were incubated at 37°C in a 
shaking water-bath (80 rpm). After 5 min of preincu- 
bation, 1 ml of the test compound (CP, 3-HAA, 
2-MF, MN or MLN) was added. Final concen- 
trations were between 0 and 2mM. Aqueous GSH 
and erythrocyte incubations were also performed in 
the presence of normal and PB-pretreated MAS, 
which was added before preincubation to a final 
protein concentration of 1 mg/ml. After 1 hr of 
incubation the samples were treated as previously 
described (Palmen and Evelo, 1993) and total 
glutathione (GT: the total of reduced plus oxidized 
glutathione) concentrations were measured. Initial 
GT concentrations were 440 + 5 FM (mean f SE) for 
aqueous GSH solutions (300 f 5 PM for 2-MF), 
235 + 20 PM for haemolysates and 110 f 4 FM for 
erythrocytes. All experiments were performed three 
times and in triplicate (3 x 3). For CP and 3-HAA, 
separate experiments were performed for test com- 
pound concentrations between 0 and 0.5 mM and 
between 0.5 and 2.0 mM. 
Incubations with hepatocytes: Hepatocytes (4.4 x 
106cells/ml) plus 3-HAA or CP solutions (final 
concentrations between 0 and 2.0 InM) were incubated 
in Krebs-Henseleit buffer (pH 7.4) for 1 hr 
(incubation volume 1.5 ml, 37°C) in a shaking water- 
bath (80 rpm). After the incubation period, 200 ~1 
trichloroacetic acid (TCA) (8%) was added to an 
equal volume of hepatocyte suspension and GT was 
determined. The rest of the sample was centrifuged 
(5 min, 25g) and 1 ml supematant plus 200 ~1 
GSH solution (final concentration between 100 and 
400 PM) was incubated again under the same con- 
ditions. In order to liberate possible conjugated 
metabolites, /I-glucuronidase/arylsulfatase was added 
(final activity of 650 U/ml, with the pH adjusted to 
6.2 by addition of 175 ~1 3 M KH,PO,). DEM pre- 
treatment was performed by incubation of 4.4 x 
lO”cells/ml with 1 mM DEM in Krebs-Henseleit 
buffer for 15 min in a shaking water-bath at 37°C. 
Excess DEM was removed by washing twice with the 
same buffer. 
Co-incubations of erythrocytes and hepatocytes: Co- 
incubations of erythrocytes and hepatocytes were 
performed in transwellsTM (Costar, Cambridge, UK), 
that are composed of a well in which a smaller well 
(transwell) can be placed containing a porous mem- 
brane (0.4pm). Erythrocytes (2.6 ml, Hb concen- 
tration 27 g/litre) were pipetted into the well, and the 
hepatocytes (1 ml, 6.6 x lo6 cells/ml) plus 3-HAA 
(0.5 ml, final concentration between 0 and 5 mM) were 
added to the transwell. After an incubation period of 
1 hr, the erythrocytes were pipetted into plastic vials 
and packed by centrifugation. Further treatment 
was as previously described (Palmen and Evelo, 1993) 
and GT concentrations were determined. These 
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experiments were performed three times in triplicate 
(3 x 3). 
Analytical procedures 
GSH was determined as previously described 
(Evelo and Henderson, 1988). GT in the TCA super- 
natants was determined after dilution (nine-fold) with 
buffer by the cyclic oxidation reduction method 
described by Anderson (1985). Lactate dehydrogen- 
ase (LDH) activity was determined using NADH 
consumption during pyruvate transformation to 
lactate (Moss et al., 1986). Microsomal and hepato- 
cyte protein contents were determined according to 
Lowry et al. (1951). Haemoglobin concentrations 
were determined by measuring cyanmethaemoglobin 
according to van Kampen and Zijlstra (1965). 
Statistical analysis 
GT depletion caused by CP, 3-HAA, 2-MF, MN 
and MLN was analysed separately for both incu- 
bations with normal and PB microsomes by linear 
regression, using a model including control value and 
concentration as explanatory variables. Using that 
model we tested, for each metabolizing system, 
whether slopes of GT depletion versus concentration 
were significant. 
RESULTS 
Incubations without addition of metabolic activating 
system 
Depletion of GSH by IAcA, NEM and DEM and 
depletion of GT by CP, 3-HAA and 2-MF in 
incubations without MAS, is shown in Figs 2, 3 and 
4 for aqueous GSH solutions, erythrocytes and 
haemolysates, respectively. 
GSH in aqueous solution was depleted by the 
direct GSH-reactive compounds IAcA, NEM and 
DEM. The most reactive compound was NEM, 
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Fig. 2. GSH depletions in aqueous solution after incubation 
with the reactive compounds IAcA (0). NEM (0) and 
DEM (A) (single experiments in triplicate: 1 x 3) and GT 
depletion in incubations with CP (A), 3-HAA (V) and 
Fig. 4. GT depletion in haemolysates by CP (A), 3-HAA 
(V) and 2-MF (0). Mean and interexperimental SE are 
shown for three experiments performed in triplicate (3 x 3). 
The GT depletion was concentration dependent for 3-HAA 
and 2-MF: asterisks indicate significant differences from 
2-MF (a) (three experiments in triplicate: 3 x 3). control (*P d 0.01 in both cases; linear regression). 
Substrate (mu) 
Fig. 3. GSH depletion in erythrocytes after incubation with 
IAcA (a), NEM (0) and DEM (A) (single experiments 
in triplicate: 1 x 3) and GT depletion in incubations with 
CP (A), 3-HAA (V) and 2-MF (0) (three experiments in 
triplicate: 3 x 3). 
0.5 mM; for IAcA a comparable effect was reached at 
1.0 mM. DEM was the least reactive compound. 
These three compounds also caused GSH depletion 
in erythrocytes, indicating that they do pass through 
erythrocyte membrane. Here, IAcA was the most 
effective compound, as 97% of the initial GSH 
concentration was depleted at a IAcA concentration 
of 2 mM, followed by NEM (82%) and DEM (45%). 
Consistent with the fact that CP, 3-HAA, 2-MF, 
MN and MLN need metabolic activation, GT was 
not depleted in incubations of these compounds with 
aqueous GSH solution or erythrocytes. In incu- 
bations of haemolysates, concentration-dependent 
GT depletion (P 6 0.01) was found for 3-HAA 
(depletion of 18 pmol/mmol 3-HAA) and 2-MF 
(12 ~mol/mmol). 
Incubations with MAS 
In incubations with aqueous GSH solution and 
normal microsomes (Fig. 5), GT was depleted in a 
5 40 * 
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Substrate (mM) 
Fig. 5. GT depletion in incubations (3 x 3) of aqueous GSH 
solution and microsomes of untreated rats with CP (A), 
3-HAA (V) and 2-MF (0). The mean and the inter- 
experimental SE are shown. The GT depletion was concen- 
tration dependent for all three compounds: asterisks 
indicate significant differences from control (**P < 0.001 in 
all cases; linear regression). 
concentration-dependent way by CP (GT depletion 
was 48 ~mol/mmol), 3-HAA (36 ~mol/mmol) and 
2-MF (25 ~mol/mmol) (P ,< 0.001 in all three cases), 
and not by MN or MLN. When PB microsomes 
were used (Fig. 6) even higher depletions were found 
for CP (92 ~mol/mmol), 2-MF (41 ~mol/mmol) and 
3-HAA. For the latter compound a plateau in GT 
depletion was found at 3-HAA concentrations above 
0.3 mM where the initial GSH concentration was 
about 25% depleted. For these microsomes, also, 
MN and MLN had no effect. 
The same profile was found for erythrocytes. In 
the presence of normal microsomes (Fig. 7), GT was 
depleted in a concentration-dependent way by CP 
(46 pmol/mmol CP), 3-HAA (11 pmol/mmol) and 
2-MF (23 pmol/mmol) (P & 0.001 in all cases). In the 
f 125 
‘E 100 ** 
.$ 
al 75 
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Fig. 7. GT depletion in incubations (3 x 3) of erythrocytes 
and microsomes of untreated rats with CP (A), 3-HAA (V) 
and 2-MF (a). The mean and interexperimental SE are 
shown. In some cases the SE falls within the datapoints. 
The GT depletion was concentration dependent for all three 
compounds: asterisks indicate significant differences from 
control (**P Q 0.001; linear regression). 
presence of PB microsomes (Fig. 8), even more 
marked depletion was found for CP (leading to full 
depletion at 0.5 mM CP), 3-HAA (depletion of 
30 ~mol/mmol 3-HAA) and 2-MF (39 ~mol/mmoI). 
Again MN and MLN had no effect, irrespective of 
the kind of microsomes used. 
All effects of microsomes reported above were 
clearly dependent on the presence of an NADPH- 
regenerating system. 
Incubations with hepatocytes 
Viability of hepatocytes. The viability of hepato- 
cytes after incubation was tested by measurement of 
LDH leakage into the medium (Jauregui et al., 1981). 
LDH leakage was low during the first 50 min of the 
incubation period and increased thereafter (data not 
250, I 
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Fig. 6. GT depletion in incubations (3 x 3) of aqueous GSH 
solution and microsomes of PB-pretreated rats with CP (A), 
3-HAA (V) and 2-MF (a). The mean and the inter- 
experimental SE are shown. In some cases the SE falls 
within the datapoints. The GT depletion was concentration 
dependent for all three compounds: asterisks indicate sig- 
nificant differences from control (*P Q 0.01 for 3-HAA; 
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Fig. 8. GT depletion in incubations (3 x 3) of erythrocytes 
and microsomes of PB-pretreated rats with CP (A), 3-HAA 
(V) and 2-MF (a). The mean and interexperimental SE 
are shown. The GT depletion was concentration dependent 
for all three compounds: asterisks indicate significant 
differences from control (*P Q 0.01 for 3-HAA and 2-MF; 
**P < 0.001 for CP; linear regression). 
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Table I. Glutathione depletion and excretion of GSH-reactive compounds from hepatocytes 










1.0 6.0 k 1.7 (n = 3) 0.6 (n = I) 
2.0 9.5 * I.4 (n = 5) 10.4 (n = 2: 6.7, 14) 
I .O 15.1 C” = I) n.d. .~ 
2.0 15.0 in = 21 10.2, 19.8) 6 (n= I) 
n.d. = not done 
All values were determined after I hr incubation of hepatocytes with 3-HAA or CP. Where 
applicable, the mean I standard error of the depletion/g protein (4 g/litre in the incubations) 
is given for the number of experiments shown; each experiment consisted of incubations in 
triplicate. Excretion of GSH reactive products was determined by reincubation (1 hr. 37°C) 
with GSH. 
shown). The LDH leakage after 1 hr of incubation 
was not increased by addition of 3-HAA or CP at 
concentrations up to 2 IIIM. Incubation of hepatocytes 
with DEM (final concentration 1 mM, 15 mm, 37°C) 
depleted 75 + 5% of the initial GT concentration but 
had no effect on the LDH leakage. 
Incubations of hepatocytes alone. The effects of 
3-HAA and CP on hepatocyte GT and the excretion 
of GSH-reactive compounds are shown in Table 1. A 
concentration-dependent hepatocyte GT depletion 
was found for 3-HAA (P < 0.01). At 2 mM 3-HAA. 
this depletion amounted to about 10 pmol/g protein. 
In two experiments with CP, comparable or some- 
what higher depletions (10 and 20 pmol/g protein at 
2 mM) were found. 
The ability of GSH-reactive metabolites to pass the 
hepatocyte membrane was tested. After completion 
of the incubation with test compound, hepatocytes 
were removed by centrifugation and the supernatants 
were reincubated with GSH for 1 hr under the same 
conditions. Table 1 shows that the GT concentration 
in the supernatants decreased as a result of the earlier 
incubation of hepatocytes with the test compound, 
indicating that GSH-reactive 3-HAA and CP 
metabolites were excreted by the hepatocytes. In one 
experiment part of the hepatocytes were pretreated 
with DEM, leading to 75 _t 5% GT depletion in the 
hepatocytes. After this pretreatment the excretion of 
GSH-reactive 3-HAA metabolites increased from 0.6 
to 6.6 PM at 1 mM 3-HAA and from 6.7 to 17.8 PM at 
2 mM 3-HAA. Electrophiles generated by hepatocytes 
may also be detoxified by conjugation to compounds 
other than GSH and excreted into the medium. 
Rashed et al. (1990) showed that 80% of 3-HAA 
metabolites formed in mice are sulfated or glu- 
curonidated. We tried to liberate GSH-reactive 
compounds from such metabolites by adding fi- 
glucuronidase/arylsulfatase to the medium of the 
second (GSH containing) incubation. However, 
addition of the esterases did not increase the GT 
depletion. 
Co -incubations of erythrocytes and hepatocytes. 
Erythrocyte GT concentration was not affected when 
erythrocytes and hepatocytes were co-incubated. 
Addition of 3-HAA to these incubations (final con- 
centrations up to 5m~) did not affect erythrocyte 
GT, neither when normal hepatocytes were used nor 
when hepatocytes from PB-pretreated rats were 
tested. In an attempt to increase the amount of 
GSH-reactive 3-HAA metabolites, the hepatocytes 
were pretreated with DEM. Although this led to 72% 
depletion in the hepatocytes, it did not affect the 
erythrocyte GT concentration. Similarly, isolation 
and incubation of 3-HAA-treated hepatocytes in 
sulfate-free medium-known to affect sulfation 
capacity (Evelo et al., 1984)-had no effect on 
erythrocyte GT in co-incubations. 
DISCUSSION 
Most cell types are more or less able to (de)toxify 
foreign chemicals. The hepatocyte is known to be 
a metabolically very active cell and erythrocytes 
have some metabolic activity also (Belvedere and 
Tursi, 1981). Foreign compounds, toxified by hepato- 
cytes by means of cytochrome P-450 activity, may 
be detoxified by phase II metabolism (e.g. glucur- 
onidation, sulfation, glutathione conjugation). This 
may lead to a shortage of hepatocyte phase II 
conjugation factors such as UDP-glucuronic acid, 
3’-phosphoadenosine-S’phosphosulfate and GSH. 
Conjugated and/or unconjugated metabolites may be 
released by the hepatocyte into the sinusoids; this 
means that erythrocytes can be exposed to these 
metabolites. When the metabolites are able to pass 
through the erythrocyte membrane, the biochemical 
functions of the erythrocyte may be affected. 
In the present investigation, we developed a set of 
in vitro test systems (Fig. 1) that may help to shed 
light on the interplay between the bioactivation and 
inactivation functions of liver and blood, using gluta- 
thione depletion as the dependent variable. A com- 
parable method was described by Tingle and Park 
(1993), who noted methaemoglobin formation in 
human erythrocytes incubated with dapsone in the 
presence of rat liver microsomes. To approach the 
in uivo situation more closely, we tested whether 
hepatocytes are able to generate GSH-reactive 
metabolites from CP or 3-HAA, and the ability of 
3-HAA metabolites to deplete erythrocyte GT. As a 
large variety of variables (besides glutathione de- 
pletion) can be. tested, the test systems may extend the 
current set of techniques. GSH is an efficient scav- 
enger of reactive electrophilic substances, especially 
Bioactivation and inactivation in liver and blood 279 
in combination with glutathione S-transferases 
(DeLeve and Kaplowitz, 1991; Mannervik and 
Danielson, 1988; Meister and Anderson, 1983). 
Because of this property, a decrease of the GSH 
concentration (glutathione depletion), caused by 
the test compound, has been used as a measure 
of the amount of GSH-reactive compounds in the 
incubate (Garle and Fry, 1989 and 1990; Garle et al., 
1988). 
IAcA, NEM and DEM are direct GSH-reactive 
compounds that need no metabolic activation (Evelo 
and Henderson, 1988). In incubations with aqueous 
GSH solution and in incubations with erythrocytes, 
GSH was, indeed, depleted. The depletion of GSH in 
solutions without biological material not only 
confirms that these compounds need no metabolic 
activation but also shows that the reactions are not 
dependent on GST. The depletion in erythrocytes 
proves that the compounds are able to pass through 
the erythrocyte membrane. CP, 3-HAA, 2-MF, MN 
and MLN did not influence GT concentrations (GT 
is the sum of both reduced and oxidized glutathione) 
of aqueous GSH solutions or erythrocytes when no 
external metabolizing system was added, indicating 
that these compounds have no direct reactivity with 
GSH. 
Both 3-HAA and 2-MF depleted GT in haemo- 
lysate but not in incubations with aqueous GSH 
solution or erythrocytes. The results indicate that a 
factor in the haemolysate is capable of metabolizing 
3-HAA and 2-MF, resulting in GSH conjugation. 
This metabolic activity cannot be explained by mere 
GST-catalysed glutathione conjugation to the parent 
compounds, as the addition of glutathione S- 
transferase n (3.2 U/ml) to the incubations with 
aqueous GSH solution and 3-HAA or 2-MF, had no 
effect on the GT concentration (data not shown). 
Only when rat MAS was added to incubations of 
CP, 3-HAA or 2-MF and aqueous GSH solution or 
erythrocytes, was GT depleted. GT depletions were 
concentration dependent when normal or PB micro- 
somes were used. The presence of NADPH was a 
requirement. This indicates that metabolites of CP, 
3-HAA and 2-MF are generated by MAS and that 
these metabolites are able to enter the erythrocyte. 
For all three compounds tested, GT depletions were 
higher in incubations with aqueous GSH solution 
than in erythrocytes when normal microsomes were 
tested. This may indicate that the erythrocyte mem- 
brane acts as a barrier for metabolites of CP, 3-HAA 
and 2-MF, generated by microsomes. If the erythro- 
cyte membrane would limit diffusion to less than 
80 nmol/hr/m* membrane, GT depletion would be 
less than 10% during the assay period and therefore 
probably would not be detectable. [The incubated 
amount of erythrocytes corresponds to 200 ~1 cells, 
containing 300 nmol GSH. The amount of GSH- 
reactive metabolite needed to deplete 10% of this 
GSH pool would be 30 nmol. The membrane surface 
of 200~1 erythrocytes is 0.36m2 (Guyton, 1986)]. 
MAS-dependent depletions by CP, 3-HAA and 2-MF 
were inducible by PB. 
Despite the fact that MN and MLN are known to 
give rise to (Cchloroanilin) Hb adducts in rats 
(Sabbioni and Neumann, 1990), and were therefore 
expected to have some activity towards GSH after 
metabolization, we did not find any such effect. 
Hepatocyte GT decreased by about 10 pmol/g 
protein in incubations with 2 mM 3-HAA, and by at 
least this amount with 2rn~ CP. Since the protein 
concentration of hepatocytes is about 200 g/litre, this 
corresponds to a GT depletion in the hepatocytes of 
about 2mM. To verify whether substantial fractions 
of the metabolites formed were excreted by the 
hepatocytes, the supernatants of the 3-HAA or CP 
hepatocyte incubations were reincubated with GSH 
during 1 hr under the same conditions. The GT 
depletion in the supernatant of incubations with 
3-HAA (2m~) was of the order of 10~~. Since the 
mean GT depletion in the hepatocytes corresponded 
to 45 nmol/ml incubate, this means that the excreted 
fraction was about 20%. It should be noted that the 
method used for the measurement of excreted metab- 
olites detects only the more stable fraction of these 
metabolites that are still present after 1 hr of incu- 
bation. Because of this it is likely that the actual 
amount of such excreted metabolites was (much) 
higher. The calculated excreted fraction must 
therefore be considered as the lower limit of the 
actual excreted fraction. Since the intracellular GSH 
depletions for CP were at least as high as those for 
3-HAA, and since the excretion seemed to be some- 
what lower for CP, the excreted fraction of CP 
metabolites is probably also lower. This led us to the 
use of 3-HAA in the co-incubations of hepatocytes 
and erythrocytes. For technical reasons enforced by 
the geometry of the ‘transwells’, the dilution of 
excreted metabolites was even higher in these coincu- 
bations (incubation volume 4.1 ml instead of 1.5 ml), 
leading to a calculated 3-HAA metabolite concen- 
tration of 3.7 pM outside the erythrocytes at the end 
of the incubation. Even if we suppose that all of this 
substance enters the erythrocytes during the exper- 
iment, erythrocyte GT depletion would have been 
only 5% and therefore not detectable. As explained 
above, the actual metabolite concentration during the 
experiments may have been higher than that detected 
at the end of the hepatocyte incubations. If we 
assume, for instance, that the actual metabolite con- 
centration was about 40 PM (i.e. 10 times higher than 
that actually detected), the necessary permeability 
coefiicient (P) for unidirectional diffusion can be 
calculated from P = [V/(A x Ac)]dc/dt (Rubinow, 
1975). Where the volume of erythrocytes in the 
incubation (V) is 200 ~1, the surface area of those 
erythrocytes (A) is 0.36 m* (see above), the calculated 
concentration gradient over the cell membranes is 
40 PM and the change of the intracellular erythrocyte 
concentration (dc/dt) must be at least 10% of the 
GSH concentration (10% of 1.5 mM) in 1 hr. This 
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means that P must be at least 5.8 x 10-s cm/set. For 
comparison, known values are about lo-’ cmjsec for 
glucose and 10-‘” cmjsec and lower for ions (Alberts 
et al., 1983). This indicates that even with this IO-fold 
higher excretion, effective depletion would have been 
detectable within 1 hr only when the diffusion uptake 
speed of the metabolites was at least 60% of the 
uptake speed of glucose. The two most important 
factors limiting erythrocyte GSH depletion are there- 
fore (a) the total erythrocyte concentration (higher 
amounts of erythrocytes leading to higher amounts of 
GSH that are more difficult to deplete in substantial 
amounts) and (b) total incubation volume (higher 
volumes leading to dilution of metabolites and 
thereby to a lower metabolite gradient over the 
membrane and thus to lower diffusion speed). 
To increase the excretion of GSH-reactive metab- 
olites by the hepatocytes, hepatocytes were preincu- 
bated with diethyl maleate in order to deplete their 
glutathione store. Whereas this treatment led to over 
70% depletion of GT in the hepatocytes, no effect of 
this treatment on erythrocyte GT was found. Since 
sulfation by isolated hepatocytes can be reduced 
extensively when no inorganic sulfate is available 
(Evelo et al., 1984) this treatment may increase the 
amount of unconjugated reactive metabolites in the 
hepatocytes and, in case of excretion, in the super- 
natant. However, isolation of hepatocytes with 
sulfate-free buffer solutions, and incubation of 
hepatocytes and erythrocytes in sulfate-free Krebs 
buffer, did not deplete erythrocyte GT when 3-HAA 
was tested. Addition of /I-glucuronidase/arylsulfatase 
to incubations composed of GSH and supernatant 
that was previously incubated with hepatocytes and 
3-HAA, also had no effect on GT depletions. 
In summary, the direct GSH-reactive compounds 
IAcA, NEM and DEM were able to enter the 
erythrocyte and deplete the erythrocyte GSH store. 
CP, 3-HAA and 2-MF depleted erythrocyte GT only 
when MAS was added, indicating that GSH-reactive 
metabolites were formed that were able to enter the 
erythrocyte. Hepatocytes also metabolized 3-HAA 
and CP into GSH-reactive metabolites. They were 
able to excrete a fraction of these GSH-reactive 
metabolites into the supernatant. For 3-HAA, no 
erythrocyte GT depletion was found in co- 
incubations of hepatocytes and erythrocytes, which 
may be explained by uptake limitation of the GSH- 
reactive metabolites into the erythrocytes. 
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